Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

ALLE

Allegion plc

Feb 06 • 04:00PM ET

179.77

+3.94 2.24 %

Industrials • Security & Protection Services • Ireland • NYSE

Peers: MAS JCI MMM AAON AOS AYI DHR IR HON

| Held by: VTI VOO VB VBR IVV SPY RSP XLI VIG XHB

Index	S&P 500	P/E	24.33	EPS (ttm)	7.39	Insider Own	0.34%	Shs Outstand	86.03M	Perf Week	8.69%
Market Cap	15.47B	Forward P/E	20.28	EPS next Y	8.86	Insider Trans	-3.05%	Shs Float	85.74M	Perf Month	13.05%
Enterprise Value	17.42B	PEG	2.40	EPS next Q	1.98	Inst Own	100.16%	Short Float	3.03%	Perf Quarter	8.42%
Income	640.40M	P/S	3.89	EPS this Y	8.72%	Inst Trans	-0.06%	Short Ratio	3.12	Perf Half Y	9.79%
Sales	3.98B	P/B	7.95	EPS next Y	8.27%	ROA	12.56%	Short Interest	2.60M	Perf YTD	12.91%
Book/sh	22.63	P/C	51.09	EPS next 5Y	8.46%	ROE	36.41%	52W High	180.68 -0.50%	Perf Year	39.28%
Cash/sh	3.52	P/FCF	22.40	EPS past 3/5Y	8.52% 9.70%	ROIC	15.48%	52W Low	116.57 54.22%	Perf 3Y	49.75%
Dividend Est.	2.03 (1.13%)	EV/EBITDA	18.15	Sales past 3/5Y	9.57% 5.74%	Gross Margin	45.12%	Volatility	2.43% 2.17%	Perf 5Y	62.95%
Dividend TTM	2.04 (1.13%)	EV/Sales	4.38	EPS Y/Y TTM	13.53%	Oper. Margin	20.97%	ATR (14)	3.59	Perf 10Y	196.85%
Dividend Ex-Date	Mar 13, 2026	Quick Ratio	1.11	Sales Y/Y TTM	6.87%	Profit Margin	16.09%	RSI (14)	78.63	Recom	2.40
Dividend Gr. 3/5Y	10.06% 12.20%	Current Ratio	1.77	EPS Q/Q	9.52%	SMA20	8.00%	Beta	1.01	Target Price	182.40
Payout	28.15%	Debt/Eq	1.16	Sales Q/Q	10.66%	SMA50	9.91%	Rel Volume	1.18	Prev Close	175.83
Employees	14400	LT Debt/Eq	1.13	Earnings	Feb 17 BMO	SMA200	12.46%	Avg Volume	833.22K	Price	179.77
IPO	Nov 18, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.04% 2.34%	Trades		Volume	985,193	Change	2.24%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-14-25	Upgrade	Barclays	Underweight → Equal Weight	$163
Jul-29-25	Upgrade	BofA Securities	Underperform → Neutral	$175
Jun-24-25	Initiated	JP Morgan	Overweight	$170
Jan-06-25	Initiated	Morgan Stanley	Equal-Weight	$137
Jun-04-24	Downgrade	Barclays	Equal Weight → Underweight	$122 → $116
Feb-23-24	Downgrade	Mizuho	Buy → Neutral	$140 → $141
Feb-21-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$139 → $140
Dec-04-23	Downgrade	Barclays	Overweight → Equal Weight	$130 → $119
Oct-19-23	Downgrade	Vertical Research	Buy → Hold	$128 → $100
Sep-06-23	Downgrade	Longbow	Buy → Neutral
Jan-03-23	Upgrade	Vertical Research	Hold → Buy	$128
Jul-11-22	Downgrade	BofA Securities	Neutral → Underperform	$110
Feb-16-22	Reiterated	Wells Fargo	Overweight	$157 → $147
Feb-16-22	Reiterated	Morgan Stanley	Equal-Weight	$146 → $134
Feb-16-22	Reiterated	Mizuho	Buy	$170 → $145
Feb-16-22	Reiterated	Credit Suisse	Neutral	$142 → $134
Dec-17-21	Initiated	Mizuho	Buy	$170
Dec-08-21	Downgrade	BofA Securities	Buy → Neutral	$163 → $142
Nov-29-21	Initiated	Atlantic Equities	Overweight	$155
Oct-08-21	Initiated	Wells Fargo	Overweight	$159

Show Previous Ratings

Feb-05-26 11:44PM	3 Unpopular Stocks We're Skeptical Of (StockStory)
05:00PM	Allegion Schedules Webcast to Announce 2025 Fourth-Quarter, Full-Year Results (Business Wire)
Feb-04-26 05:00PM	Allegion's Board Increases Quarterly Dividend by 8% (Business Wire)
Feb-02-26 10:23AM	Johnson Controls Set to Report Q1 Earnings: What to Expect? (Zacks)
10:21AM	Stanley Black Gears Up to Report Q4 Earnings: What's in the Offing? (Zacks)
06:19AM	Loading…
06:19AM	Zacks Industry Outlook Highlights Allegion, Resideo Technologies, Napco Security Technologies and Intellicheck (Zacks)
Jan-30-26 11:23AM	Illinois Tool Gears Up to Report Q4 Earnings: What's in the Cards? (Zacks)
10:27AM	4 Security & Safety Stocks to Consider on Prospering Industry Trends (Zacks)
Jan-27-26 11:58AM	Otis Stock to Report Q4 Earnings: Here's What You Need to Know (Zacks)
10:10AM	Parker-Hannifin Gears Up to Report Q2 Earnings: What's in the Offing? (Zacks)
Jan-26-26 09:20AM	Allegion Gains From Business Strength Despite Persisting Headwinds (Zacks)
Jan-22-26 10:18AM	Are Options Traders Betting on a Big Move in Allegion Stock? (Zacks)
09:10AM	Jim Cramer on Allegion: "It's Not That Expensive" (Insider Monkey)
Jan-20-26 09:41AM	Schlage Named America's Most Trusted Lock Brand for Seventh Consecutive Year (PR Newswire)
Jan-16-26 09:20AM	3M Gears Up to Report Q4 Earnings: What's in the Offing? (Zacks)
07:07AM	Loading…
07:07AM	Allegion Earnings Preview: What to Expect (Barchart)
Jan-14-26 09:50AM	Here's Why Allegion (ALLE) is a Strong Momentum Stock (Zacks)
Jan-12-26 11:35PM	1 Safe-and-Steady Stock with Impressive Fundamentals and 2 We Avoid (StockStory)
Jan-08-26 09:45AM	Why Allegion (ALLE) is a Top Growth Stock for the Long-Term (Zacks)
Dec-26-25 09:40AM	Is Allegion (ALLE) Outperforming Other Industrial Products Stocks This Year? (Zacks)
Dec-23-25 09:45AM	Here's Why Allegion (ALLE) is a Strong Growth Stock (Zacks)
Dec-16-25 04:01PM	Why Allegion (ALLE) Shares Are Sliding Today (StockStory)
05:22AM	Allegion Stock: Is ALLE Outperforming the Industrial Sector? (Barchart)
Dec-15-25 10:37PM	Electrical Systems Stocks Q3 Teardown: Allegion (NYSE:ALLE) Vs The Rest (StockStory)
Dec-12-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Dec-11-25 11:02PM	Allegion (ALLE): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Dec-05-25 09:45AM	Why Allegion (ALLE) is a Top Growth Stock for the Long-Term (Zacks)
Dec-04-25 09:40AM	Why Allegion (ALLE) is a Top Value Stock for the Long-Term (Zacks)
07:30AM	Allegion Declares Quarterly Dividend (Business Wire)
Nov-20-25 07:53AM	Is Wall Street Bullish or Bearish on Allegion Stock? (Barchart)
10:00AM	Loading…
Nov-18-25 10:00AM	Allegion Unveils Self-Adjusting Enhancement to its LCN Senior Swing Series of Auto Operators (PR Newswire)
09:45AM	Here's Why Allegion (ALLE) is a Strong Growth Stock (Zacks)
Nov-17-25 09:41AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
09:02AM	Schlage's Pin & Tumbler Studio Unveils the Refined Finishes Collection: A Celebration of Quiet Elegance and Modern Craftsmanship (PR Newswire)
Nov-13-25 12:01PM	Allegion Announces Expanded Wallet-Based Access Control Solutions with Zentra and Gatewise at OPTECH 2025 (PR Newswire)
Nov-12-25 09:02AM	SCHLAGE ARRIVE SELECTED AS A GOOD HOUSEKEEPING 2026 HOME RENO AWARD WINNER (PR Newswire)
Nov-11-25 02:30PM	Technical Glass Products Continues Sustainability Efforts with Latest EPD (PR Newswire)
Nov-10-25 12:55PM	Here's Why You Should Retain Allegion Stock in Your Portfolio (Zacks)
Nov-05-25 05:00PM	Allegion to Attend 2025 Baird Global Industrial Conference (Business Wire)
Oct-30-25 01:37AM	Allegion's Q3 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Oct-29-25 12:55PM	Brivo and Allegion Americas Introduce New Standard in Connected Access Control (PR Newswire)
09:45AM	Why Allegion (ALLE) is a Top Growth Stock for the Long-Term (Zacks)
Oct-24-25 01:32AM	ALLE Q3 Deep Dive: M&A and Electronics Growth Offset Residential Softness (StockStory)
Oct-23-25 03:32PM	Analyst Report: Allegion plc (Morningstar Research)
03:06PM	Allegion PLC (ALLE) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
11:22AM	Allegion's Q3 Earnings & Revenues Surpass Estimates, Increase Y/Y (Zacks)
07:10AM	Allegion (ALLE) Beats Q3 Earnings and Revenue Estimates (Zacks)
06:30AM	Allegion's (NYSE:ALLE) Q3 Sales Beat Estimates (StockStory)
06:09AM	Allegion: Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	Allegion (NYSE: ALLE) Reports Q3-2025 Financial Results (Business Wire)
Oct-22-25 11:18AM	Illinois Tool Gears Up to Report Q3 Earnings: What to Expect? (Zacks)
Oct-21-25 11:11PM	Allegion (ALLE) Q3 Earnings: What To Expect (StockStory)
09:15AM	What Analyst Projections for Key Metrics Reveal About Allegion (ALLE) Q3 Earnings (Zacks)
Oct-20-25 09:53AM	Allegion Gears Up to Report Q3 Earnings: Is a Beat in the Offing? (Zacks)
07:47AM	Honeywell Gears Up to Report Q3 Earnings: Is a Beat in Store? (Zacks)
Oct-19-25 07:33AM	Tesla, Netflix set to report earnings as US-China trade fight turns 'unsustainable': What to watch this week (Yahoo Finance)
Oct-17-25 12:10PM	Why Allegion (ALLE) is Poised to Beat Earnings Estimates Again (Zacks)
Oct-15-25 08:00AM	Zentra Brings Resident Key in Google Wallet to Customers (PR Newswire)
Oct-13-25 08:47AM	Century Aluminum Extends Power Deal, Plans $50M Reactivation (Zacks)
Oct-08-25 09:40AM	Are Industrial Products Stocks Lagging Allegion (ALLE) This Year? (Zacks)
Oct-07-25 05:00PM	Allegion Schedules Conference Call, Webcast to Announce 2025 Third-Quarter Results (Business Wire)
10:26AM	Do Options Traders Know Something About Allegion Stock We Don't? (Zacks)
Oct-06-25 08:04AM	What You Need to Know Ahead of Allegion's Earnings Release (Barchart)
Oct-02-25 11:35PM	Electrical Systems Stocks Q2 Teardown: Allegion (NYSE:ALLE) Vs The Rest (StockStory)
Sep-26-25 01:15PM	Next Gen Overtur OnSite App Delivers Faster, Smarter Field Inspections for Building Owners and Consultants (PR Newswire)
Sep-25-25 12:47PM	Schlage Expands Commercial Portfolio with New Performance Series Locks (PR Newswire)
Sep-24-25 02:11AM	Is Allegion Stock Outperforming the Dow? (Barchart)
Sep-22-25 09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
09:40AM	Is Allegion (ALLE) Stock Outpacing Its Industrial Products Peers This Year? (Zacks)
09:25AM	Allegion PLC (ALLE) Hits Fresh High: Is There Still Room to Run? (Zacks)
Sep-19-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Sep-12-25 01:01AM	Allegion (ALLE) Shows Operational Rigor Amid Mixed Market Conditions, Says Mizuho (Insider Monkey)
Sep-10-25 12:03AM	3 Reasons to Avoid ALLE and 1 Stock to Buy Instead (StockStory)
Sep-04-25 05:00PM	Allegion Declares Quarterly Dividend (Business Wire)
Sep-03-25 05:00PM	Allegion to Attend 2025 Morgan Stanley Annual Laguna Conference (Business Wire)
09:45AM	Here's Why Allegion (ALLE) is a Strong Growth Stock (Zacks)
Sep-02-25 02:26PM	Allegion (ALLE) Stock Trades Down, Here Is Why (StockStory)
Aug-26-25 08:25AM	Are Wall Street Analysts Bullish on Allegion Stock? (Barchart)
Aug-21-25 06:16AM	New Strong Buy Stocks for August 21st (Zacks)
Aug-19-25 12:13PM	Here's Why You Should Consider Investing in Allegion Stock Right Now (Zacks)
08:33AM	Bank of America Isnt Sold on These 2 New Warren Buffett Stock Picks (TipRanks)
04:47AM	Warren Buffett Just Invested $3.9 Billion in 12 Stocks. Here's the Best of the Bunch. (Motley Fool)
Aug-15-25 10:30AM	Berkshire Hathaway buys $1.6B stake in UnitedHealth, stock jumps (Quartz)
Aug-14-25 06:42PM	Berkshire Hathaway 13F Filing Reveals Warren Buffett's Secret Stock (Investopedia)
05:53PM	Warren Buffett's Berkshire Further Pares Stake in Apple, Adds UnitedHealth Position (The Wall Street Journal)
05:01PM	UnitedHealth shares jump sharply as Buffetts Berkshire shows new stake (Investing.com)
04:58PM	Berkshire invests in UnitedHealth, trims Apple stake (Reuters)
09:40AM	Are Industrial Products Stocks Lagging Allegion (ALLE) This Year? (Zacks)
Aug-13-25 12:00PM	Allegion (ALLE) Upgraded to Strong Buy: Here's Why (Zacks)
08:30AM	Allegion Acquires Brisant, Leading UK Provider of Residential Security Hardware (Business Wire)
Aug-12-25 10:47AM	Zacks Industry Outlook Highlights Allegion, Life360 and Alarm.com (Zacks)
Aug-11-25 10:39AM	4 Security & Safety Stocks to Consider on Promising Industry Trends (Zacks)
Aug-06-25 11:17AM	Powell Industries Q3 Earnings Surpass Estimates, Revenues Miss (Zacks)
08:30AM	Allegion Ventures Makes Strategic Investment in Asylon Robotics (Business Wire)
Aug-05-25 08:30AM	Is the Options Market Predicting a Spike in Allegion Stock? (Zacks)
Aug-04-25 10:50AM	RBC Bearings Q1 Earnings & Revenues Surpass Estimates, Rise Y/Y (Zacks)
08:30AM	Allegion Acquires Leading UK Security Solutions Provider UAP, Further Expanding Core Mechanical Portfolio (Business Wire)
04:30AM	[Latest] Global Door Closer Market Size/Share Worth USD 5.83 Billion by 2034 at a 4.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
Jul-31-25 01:32AM	Allegion's Q2 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Jul-30-25 10:00AM	Best Momentum Stocks to Buy for July 30th (Zacks)

Allegion Plc engages in the provision of security products and solutions that keep people safe, secure, and productive. It operates through the Allegion Americas and Allegion International segments. The Allegion Americas segment offers security products, services, and solutions throughout North America. The Allegion International segment refers to security products, services, and solutions primarily throughout Europe, Asia and Oceania. The company was founded on May 9, 2013 and is headquartered in Dublin, Ireland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PETERS LAUREN B	Director	Nov 25 '25	Buy	165.44	1,600	264,705	6,481	Nov 25 03:36 PM
Eckersley Timothy P	SVP - Allegion International	Aug 07 '25	Sale	164.76	10,810	1,781,070	30,023	Aug 11 02:44 PM
Timothy Eckersley	Officer	Aug 07 '25	Proposed Sale	84.84	10,810	917,142		Aug 07 04:16 PM
Kemp Tracy L	SVP-Chief Info. & Digital Ofr	Jul 25 '25	Option Exercise	86.93	2,349	204,199	12,622	Jul 29 02:57 PM
Kemp Tracy L	SVP-Chief Info. & Digital Ofr	Jul 25 '25	Sale	164.92	3,849	634,786	8,773	Jul 29 02:57 PM
Tracy Kemp	Officer	Jul 25 '25	Proposed Sale	164.89	3,849	634,653		Jul 25 04:47 PM
Jeffrey Braun	Former Officer	Jul 25 '25	Proposed Sale	163.73	10,776	1,764,332		Jul 25 04:14 PM
Wenos Vincent	SVP - Chief Technology Officer	May 09 '25	Option Exercise	71.83	961	69,033	11,395	May 13 04:50 PM
Wenos Vincent	SVP - Chief Technology Officer	May 09 '25	Sale	141.88	961	136,342	10,434	May 13 04:50 PM
Vincent Wenos	Officer	May 09 '25	Proposed Sale	141.87	961	136,337		May 09 04:45 PM
Kemp Tracy L	SVP-Chief Info. & Digital Ofr.	Mar 11 '25	Sale	126.74	2,032	257,541	10,273	Mar 12 07:24 PM
Braun Jeffrey N	SVP, GC and Secretary	Mar 10 '25	Sale	134.68	2,018	271,788	3,077	Mar 12 07:06 PM
Tracy Kemp	Officer	Mar 11 '25	Proposed Sale	126.74	2,032	257,541		Mar 11 04:51 PM
Jeffrey Braun	Officer	Mar 10 '25	Proposed Sale	134.68	2,018	271,787		Mar 10 05:02 PM
Ilardi David S.	SVP - Allegion Americas	Mar 04 '25	Option Exercise	57.85	789	45,644	10,414	Mar 06 05:25 PM
Ilardi David S.	SVP - Allegion Americas	Mar 04 '25	Sale	125.28	789	98,846	9,625	Mar 06 05:25 PM
Wagnes Michael J.	Sr. VP & CFO	Feb 28 '25	Option Exercise	57.85	1,577	91,229	24,627	Mar 04 06:39 PM
David Ilardi	Officer	Mar 04 '25	Proposed Sale	125.25	789	98,819		Mar 04 04:38 PM
SENGSTACK GREGG C	Director	Feb 19 '25	Buy	125.24	8,000	1,001,920	8,000	Feb 21 05:19 PM
Musial Nickolas A.	VP, Controller & CAO	Feb 19 '25	Option Exercise	57.85	403	23,314	5,375	Feb 19 07:08 PM
Musial Nickolas A.	VP, Controller & CAO	Feb 19 '25	Sale	124.70	403	50,254	4,972	Feb 19 07:08 PM
Nickolas Musial	Officer	Feb 19 '25	Proposed Sale	124.70	403	50,255		Feb 19 04:56 PM

Open in Screener

MRK

Merck & Co Inc

Feb 06 • 04:00PM ET

121.93

+2.18 1.82 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: PFE AZN-D NVS BMY JNJ AMGN ABBV GSK LLY SNY

| Held by: VTI VOO IVV SPY SCHD VTV XLV VIG VYM DGRO

Index	DJIA, S&P 500	P/E	16.76	EPS (ttm)	7.28	Insider Own	0.13%	Shs Outstand	2.48B	Perf Week	10.57%
Market Cap	302.63B	Forward P/E	12.45	EPS next Y	9.79	Insider Trans	-5.95%	Shs Float	2.48B	Perf Month	12.27%
Enterprise Value	325.81B	PEG	2.09	EPS next Q	-1.50	Inst Own	79.62%	Short Float	1.36%	Perf Quarter	44.48%
Income	18.25B	P/S	4.66	EPS this Y	-41.67%	Inst Trans	-1.47%	Short Ratio	2.30	Perf Half Y	51.71%
Sales	65.00B	P/B	5.85	EPS next Y	86.97%	ROA	15.41%	Short Interest	33.65M	Perf YTD	15.84%
Book/sh	20.85	P/C	16.58	EPS next 5Y	5.95%	ROE	39.51%	52W High	122.43 -0.41%	Perf Year	35.98%
Cash/sh	7.35	P/FCF	23.19	EPS past 3/5Y	8.43% 21.23%	ROIC	19.88%	52W Low	73.31 66.32%	Perf 3Y	13.97%
Dividend Est.	3.25 (2.66%)	EV/EBITDA	10.92	Sales past 3/5Y	3.60% 9.37%	Gross Margin	81.50%	Volatility	3.71% 2.65%	Perf 5Y	65.30%
Dividend TTM	3.28 (2.69%)	EV/Sales	5.01	EPS Y/Y TTM	58.02%	Oper. Margin	41.18%	ATR (14)	3.06	Perf 10Y	152.36%
Dividend Ex-Date	Mar 16, 2026	Quick Ratio	1.44	Sales Y/Y TTM	1.61%	Profit Margin	28.08%	RSI (14)	78.08	Recom	1.97
Dividend Gr. 3/5Y	5.42% 5.75%	Current Ratio	1.66	EPS Q/Q	-19.28%	SMA20	9.51%	Beta	0.28	Target Price	121.26
Payout	45.05%	Debt/Eq	0.80	Sales Q/Q	7.24%	SMA50	14.53%	Rel Volume	0.90	Prev Close	119.75
Employees	75000	LT Debt/Eq	0.77	Earnings	Feb 03 BMO	SMA200	37.25%	Avg Volume	14.61M	Price	121.93
IPO	Jun 15, 1946	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.43% 1.24%	Trades		Volume	13,079,052	Change	1.82%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-26	Upgrade	Wolfe Research	Peer Perform → Outperform	$135
Dec-18-25	Upgrade	BMO Capital Markets	Market Perform → Outperform	$130
Nov-24-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$125
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$105
Oct-13-25	Resumed	Citigroup	Neutral	$95
Sep-17-25	Downgrade	Berenberg	Buy → Hold	$90
May-14-25	Downgrade	Citigroup	Buy → Neutral	$84
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$85
Feb-18-25	Downgrade	Deutsche Bank	Buy → Hold	$128 → $105
Feb-10-25	Downgrade	TD Cowen	Buy → Hold	$121 → $100
Jan-08-25	Downgrade	Truist	Buy → Hold	$110
Dec-20-24	Downgrade	BMO Capital Markets	Outperform → Market Perform	$136 → $105
Dec-10-24	Resumed	BofA Securities	Buy	$121
Dec-04-24	Upgrade	HSBC Securities	Hold → Buy	$130
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-11-24	Downgrade	Daiwa Securities	Buy → Neutral
Oct-17-24	Initiated	Bernstein	Mkt Perform	$115
Mar-11-24	Downgrade	Societe Generale	Hold → Sell	$104
Jan-04-24	Upgrade	TD Cowen	Market Perform → Outperform	$125 → $135
Nov-09-23	Initiated	Deutsche Bank	Buy	$115

Show Previous Ratings

Feb-06-26 04:15PM	The Dow Industrials Have Tilted More Toward Financials (The Wall Street Journal)
12:53PM	Big-Name Earnings, Selloffs Highlight Busy Week on Wall Street (Schaeffer's Research)
11:06AM	Pfizer Bets Big on Obesity and Oncology With 2026 Pipeline Push (Zacks)
11:04AM	Merck's Subdued 2026 Outlook: What it Means After Q4 Results? (Zacks)
09:28AM	Low Volatility ETFs to Watch Amid Major Tech Sell-Off Over AI Panic (Zacks)
07:08AM	Loading…
07:08AM	White Houses online service for drug sales debuts with limited impact on prices (BioPharma Dive)
Feb-05-26 02:38PM	Scotiabank Lifts Merck (MRK) Target as Execution Continues to Impress (Insider Monkey)
01:21PM	Merck veteran Perlmutter-led Eikon Therapeutics valued at $860 million in Nasdaq debut (Reuters)
09:15AM	Should You Buy, Hold, or Sell GILD Stock Ahead of Q4 Earnings? (Zacks)
08:31AM	AstraZeneca to Report Q4 Earnings: What's in Store for the Stock? (Zacks)
07:58AM	Rapid Innovation is Reshaping Oncology: Stocks in Focus (Zacks)
05:44AM	J.P. Morgan Healthcare Conference 2026 Report (Pharmaceutical Technology)
03:00AM	Big Pharma CEOs set sights on massive growth in years to come (Pharma Voice)
Feb-04-26 03:18PM	Jim Cramer on Merck & Co.: "This Is One of My Favorite Pharmaceutical Stocks" (Insider Monkey)
12:16PM	S&P 500 Slips, Nasdaq Drops as Traders Dump Chips (Schaeffer's Research)
10:16AM	Loading…
10:16AM	Stock Market Today: Dow Rises But Nasdaq Lags On Surprise Jobs Data; Eli Lilly Soars (Live Coverage) (Investor's Business Daily)
01:08AM	Merck & Co., Inc. Q4 Earnings Call Highlights (MarketBeat)
12:35AM	MRK Q4 Deep Dive: Pipeline Expansion and New Product Launches Shape Guidance (StockStory)
Feb-03-26 04:26PM	Stocks Tumble on AI Disruption Fears (Barchart)
04:02PM	Merck & Co Inc (MRK) Q4 2025 Earnings Call Highlights: Strong Growth Amidst Challenges (GuruFocus.com)
03:42PM	Analyst Report: Merck & Co., Inc. (Morningstar Research)
02:56PM	Pfizer Stock Falls After Solid Earnings. Whats Troubling Wall Street. (Barrons.com)
02:46PM	These Stocks Are Todays Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More (Barrons.com)
02:43PM	Merck Stock Gains as Earnings Top Estimates. Momentum Is Building, Says CEO. (Barrons.com)
12:40PM	MSDs 2026 sales forecast falls short amid patent losses despite strong Q4 (Pharmaceutical Technology)
12:30PM	Dow Hits Record, Nasdaq Sinks as Tech Stocks Retreat (GuruFocus.com)
12:18PM	Merck 2026 Outlook Misses as Gardasil Sales Drop 35% (GuruFocus.com)
12:15PM	Dow's Early Record Fades as Tech Turns South (Schaeffer's Research)
11:36AM	MRK Q4 Earnings & Sales Beat Estimates, Stock Down on Weak '26 View (Zacks)
11:06AM	Merck's Annual Outlook Falls Short But Keytruda, Animal Health Segments Grow (Benzinga)
11:04AM	Loading…
11:04AM	2 Pharma Stocks React to Quarterly Results, Guidance (Schaeffer's Research)
11:00AM	Merck (MRK) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
11:00AM	Market Awaits JOLTS Jobs Report (Zacks)
10:26AM	Q4 Earnings, JOLTS & a Changing of the Disney Guard (Zacks)
10:17AM	Stock Market Today: Dow Inches Higher As Palantir Rallies; Rambus Tumbles (Live Coverage) (Investor's Business Daily)
09:27AM	Here's Why Gilead Sciences Stock Surged 21% in a Month (Zacks)
08:19AM	Pharma stocks slump as Pfizer and Merck report earnings (Quartz)
08:19AM	Merck and Pfizer decline vs the broader market as results released (Quartz)
07:40AM	Merck (MRK) Q4 Earnings and Revenues Beat Estimates (Zacks)
07:24AM	Jim Cramer on Merck & Co.: "I Think It Can Spread Out the Wealth" (Insider Monkey)
07:11AM	Merck shares fall as 2026 guidance disappoints despite solid Q4 results (Investing.com)
06:55AM	Merck's outlook for 2026 comes in lower-than-expected as pipeline faces make-or-break year (MarketWatch)
06:48AM	Merck's (NYSE:MRK) Q4 CY2025 Sales Beat Estimates (StockStory)
06:48AM	Merck Earnings Top Estimates. Why the Stock Is Falling. (Barrons.com)
06:40AM	Merck: Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline (Business Wire)
05:00AM	Advanced Micro Devices heads earnings slate (MarketWatch)
04:34AM	Where is Merck & Co. (MRK) Headed According to Wall Street? (Insider Monkey)
04:19AM	Stock Market Today: S&P 500 eyes fresh record as Dow and Nasdaq also called higher; Palantir rises after earnings; gold and silver rebound; AMD results on tap. (MarketWatch)
03:39AM	Stocks to Watch Tuesday: Palantir, Teradyne, AMD (The Wall Street Journal)
03:01AM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
Feb-02-26 07:00PM	AMD earnings, Netflix-Warner Bros. hearing: What to Watch (Yahoo Finance Video)
06:02PM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
05:46PM	Market Indexes Bounce Back to Start a New Trading Week (Zacks)
11:40AM	Merck Reports Earnings Tuesday Morning After Gaining 13% Over the Past Year (24/7 Wall St.)
11:12AM	Market Awaits January Manufacturing Numbers (Zacks)
10:35AM	Six More Weeks of Q4 Earnings Season? (Zacks)
10:25AM	What's in Store for These 5 Pharma Bigwigs This Earnings Season? (Zacks)
08:29AM	Palantir, AMD, Amazon and More Stocks with Earnings This Week (Benzinga)
07:00AM	Option Volatility And Earnings Report For February 2 - 6 (Barchart)
02:13AM	Jobs Report, Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
Feb-01-26 10:04PM	Merck (MRK) Q4 Earnings Report Preview: What To Look For (StockStory)
07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-31-26 12:35PM	Merck & Co., Inc. (MRK) Joins BofA's "US 1 List" (Insider Monkey)
Jan-30-26 05:45PM	Merck (MRK) Advances While Market Declines: Some Information for Investors (Zacks)
04:57PM	Jobs Report, More Tech Earnings: What to Watch Next Week (The Wall Street Journal)
12:36PM	This Pharma Stock Eyes Entries, Battles For Key Level Amid 68% Earnings Growth (Investor's Business Daily)
09:41AM	Merck & Co. Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
09:09AM	Stock Market Today: Dow Falls On Surprise Inflation Data, Warsh Nomination; Tesla Rallies (Live Coverage) (Investor's Business Daily)
08:49AM	Will BMY's Oncology Collaborations Drive Its Next Growth Phase? (Zacks)
07:50AM	Buy, Sell or Hold MRK Stock: Key Factors to Watch Before Q4 Earnings (Zacks)
03:51AM	Heard on the Street Thursday Recap: Gold Swings (The Wall Street Journal)
Jan-29-26 05:50PM	Why the Market Dipped But Merck (MRK) Gained Today (Zacks)
12:28PM	FDA Accepts Summit's Lung Cancer Drug Application, Review Underway (Benzinga)
09:15AM	Curious about Merck (MRK) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
09:00AM	Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jan-28-26 09:05PM	This Stock Is Already Up 58% This Year. Is It a Buy? (Motley Fool)
12:47PM	Pharma Stocks Are Close to 'Breaking Out.' Earnings Could Set Them Free. (Barrons.com)
10:15AM	Merck's Non-Oncology Drugs Q4 Performance: What to Expect (Zacks)
10:00AM	AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
09:30AM	Brokers Suggest Investing in Merck (MRK): Read This Before Placing a Bet (Zacks)
Jan-27-26 03:07PM	Merck Announces Second-Quarter 2026 Dividend (Business Wire)
02:51PM	3 Healthcare ETFs to Buy as Flat Medicare Rate Proposal Hits Insurers (Zacks)
12:51PM	Kazia Therapeutics Reports Positive Early Responses In Aggressive Breast Cancer Trial (Benzinga)
10:53AM	RVMD Stock Tumbles as MRK Reportedly Withdraws Buyout Offer (Zacks)
10:50AM	Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks (PR Newswire)
10:45AM	Pfizer, Merck, CoreWeave, Zoom: Top Analyst Calls (Yahoo Finance Video)
10:37AM	2 Pharmaceutical Stocks Set to Rebound in 2026 (Motley Fool)
10:00AM	Merck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
02:14AM	Merck's (MRK) Quality is Clear, but Growth Visibility Matters, TD Cowen Notes (Insider Monkey)
Jan-26-26 07:36PM	Why Revolution Medicines Stock Plummeted by Almost 17% Today (Motley Fool)
04:56PM	Stocks to Watch Monday Recap: CoreWeave, IonQ, USA Rare Earth, RevMed (The Wall Street Journal)
01:48PM	Stocks to Watch Monday: CoreWeave, IonQ, USA Rare Earth, RevMed (The Wall Street Journal)
01:12PM	Stock Market Today: Trump's Medicare announcement slams health insurers (TheStreet)
12:47PM	Merck Ends Acquisition Talks With Revolution Medicines After Valuation Dispute (GuruFocus.com)
11:15AM	Moderna (MRNA) Stock Pulls Back After Recent Strength (Benzinga)
09:09AM	Revolution Medicines stock falls after Merck reportedly ends acquisition pursuit (Investing.com)
07:52AM	Why Is Cancer Drug Developer Erasca Stock Trading Lower Monday? (Benzinga)
07:19AM	MSD ends takeover talks with Revolution Medicines (Pharmaceutical Technology)
06:01AM	Revolution Medicines Stock Sinks After Merck Deal Talks Collapse (Benzinga)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RICHARD ROBERT DELUCA JR.	Officer	Feb 06 '26	Proposed Sale	120.92	37,685	4,557,025		Feb 06 04:35 PM
DAVID WILLIAMS	Officer	Feb 06 '26	Proposed Sale	121.91	5,000	609,525		Feb 06 04:33 PM
Williams David Michael	EVP,Chief Info&Digital Officer	Feb 06 '26	Option Exercise	77.62	5,000	388,100	35,838	Feb 06 04:20 PM
Williams David Michael	EVP,Chief Info&Digital Officer	Feb 06 '26	Sale	121.91	5,000	609,525	30,838	Feb 06 04:20 PM
JOHANNES JACOBUS OOSTHUIZEN	Officer	Feb 06 '26	Proposed Sale	121.87	15,000	1,827,992		Feb 06 04:19 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Feb 04 '26	Option Exercise	62.07	4,000	248,280	14,605	Feb 06 04:18 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Feb 04 '26	Sale	119.67	6,400	765,920	8,205	Feb 06 04:18 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	Feb 06 '26	Sale	121.87	15,000	1,827,992	21,197	Feb 06 04:15 PM
Litchfield Caroline	EVP & CFO	Feb 04 '26	Option Exercise	53.06	41,997	2,228,361	132,189	Feb 06 04:13 PM
Litchfield Caroline	EVP & CFO	Feb 04 '26	Sale	119.61	41,997	5,023,312	90,192	Feb 06 04:13 PM
Li Dean Y	Executive VP & President, MRL	Feb 04 '26	Option Exercise	56.04	15,087	845,475	117,357	Feb 06 04:12 PM
Li Dean Y	Executive VP & President, MRL	Feb 04 '26	Sale	118.77	15,087	1,791,824	102,270	Feb 06 04:12 PM
Guindo Chirfi	Chief Marketing Officer	Feb 05 '26	Sale	121.88	20,000	2,437,676	80,615	Feb 06 04:10 PM
DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Feb 06 '26	Sale	120.92	37,685	4,557,025	160,174	Feb 06 04:08 PM
Davis Robert M	Chairman, CEO & President	Feb 04 '26	Sale	118.04	47,434	5,599,327	443,602	Feb 06 04:05 PM
CHIRFI GUINDO	Officer	Feb 05 '26	Proposed Sale	121.88	20,000	2,437,676		Feb 05 04:25 PM
DALTON SMART	Officer	Feb 04 '26	Proposed Sale	119.67	6,400	765,920		Feb 04 04:38 PM
ROBERT M. DAVIS	Officer	Feb 04 '26	Proposed Sale	118.02	47,434	5,598,137		Feb 04 04:29 PM
DEAN LI	Officer	Feb 04 '26	Proposed Sale	118.77	15,087	1,791,824		Feb 04 04:27 PM
CAROLINE A LITCHFIELD	Officer	Feb 04 '26	Proposed Sale	119.61	41,997	5,023,312		Feb 04 04:26 PM
Downing Cristal N	Chief Comm. & Public Afrs Ofcr	Nov 10 '25	Sale	87.00	7,085	616,395	0	Nov 12 04:01 PM
CRISTAL DOWNING	Officer	Nov 10 '25	Proposed Sale	87.00	7,085	616,395		Nov 10 04:07 PM
Williams David Michael	EVP,Chief Info&Digital Officer	Nov 03 '25	Sale	83.59	8,614	720,040	24,578	Nov 04 04:02 PM
DAVID WILLIAMS	Officer	Nov 03 '25	Proposed Sale	83.59	8,614	720,040		Nov 03 04:09 PM
Williams David Michael	EVP,Chief Info&Digital Officer	Aug 04 '25	Option Exercise	79.29	17,119	1,357,366	41,445	Aug 05 08:46 AM
Guindo Chirfi	Chief Marketing Officer	Aug 04 '25	Option Exercise	79.29	36,903	2,926,039	107,409	Aug 05 08:43 AM
Smart Dalton E. III	SVP Fin. - Global Controller	May 03 '25	Option Exercise	83.18	2,050	170,519	10,127	May 05 04:23 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Apr 30 '25	Option Exercise	84.71	464	39,305	8,242	May 02 04:18 PM
Smart Dalton E. III	SVP Fin. - Global Controller	May 02 '25	Option Exercise	83.26	381	31,722	8,464	May 02 04:18 PM
Romanelli Joseph	President, Human Health Int?l	May 02 '25	Option Exercise	83.26	2,262	188,334	24,061	May 02 04:14 PM
Romanelli Joseph	President, Human Health Int?l	Apr 30 '25	Option Exercise	84.71	2,063	174,757	22,816	May 02 04:14 PM
Larson Betty D	EVP, Chief HR Officer	Apr 30 '25	Option Exercise	84.71	11,350	961,458	11,350	May 02 04:12 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Apr 25 '25	Option Exercise	58.08	5,000	290,400	12,040	Apr 29 04:04 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Apr 25 '25	Sale	82.76	4,262	352,723	7,778	Apr 29 04:04 PM
DALTON SMART	Officer	Apr 25 '25	Proposed Sale	82.76	4,262	352,723		Apr 25 04:05 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	Feb 19 '25	Sale	84.09	8,500	714,745	30,705	Feb 20 04:01 PM
JOHANNES JACOBUS OOSTHUIZEN	Officer	Feb 19 '25	Proposed Sale	84.09	8,500	714,745		Feb 19 05:09 PM
DAVID WILLIAMS	Officer	Feb 13 '25	Proposed Sale	85.34	6,000	512,057		Feb 13 04:10 PM
Williams David Michael	EVP,Chief Info&Digital Officer	Feb 13 '25	Sale	85.34	6,000	512,057	24,123	Feb 13 04:01 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	Feb 08 '25	Option Exercise	87.28	13,002	1,134,815	45,609	Feb 11 02:59 PM

ALLE

Allegion plc

MRK

Merck & Co Inc

Upgrade your FINVIZ experience